What You Should Know About Pediatric HIV Treatment: A Conversation With Annie Buchanan, MD, MPH

There are not as many treatment options for children with HIV as there are for adults living with HIV. But there are more options than ever, and maybe one more on the horizon. The FDA has accepted a New Drug Application to review a new dispersible tablet form of dolutegravir-lamivudine (Dovato, ViiV Healthcare) for children and lower the age range of the indication to include more children. Annie Buchanan, MD, MPH, DTMH, the pediatric medicines development lead for ViiV Healthcare, sat down with Infectious Disease Special Edition to talk about this new NDA and the landscape of pediatric HIV therapies. Want more infectious disease news, insights, and research highlights? ✨ Subscribe to our channel 🔗 Check us out: https://www.idse.net/ 🐦 Follow us! X: https://x.com/IDSE_Online LinkedIn:   / infectious-disease-special-edition   Facebook:   / idseonline   Instagram:   / idseonline   Hit the notification bell 🔔 so you’re always in the loop!